Alan H Auerbach
CEO, President at Puma Biotechnology, Inc. (PBYI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $569K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 8SEC | PBYIPuma Biotechnology, Inc. | Sell Plan | 44,0587,261,671 held (−1%) | $8.26 | $364K | +19.0% |
| Jan 8SEC | PBYIPuma Biotechnology, Inc. | Sell Plan | 16,9387,163,963 held (−0%) | $5.84 | $99K | +68.3% |
| Jan 8SEC | PBYIPuma Biotechnology, Inc. | Sell Plan | 18,0127,145,951 held (−0%) | $5.88 | $106K | +67.2% |
- Sell
CEO, President Alan H Auerbach sold $364K of PBYI at $8.26 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Alan H Auerbach sold $99K of PBYI at $5.84 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Alan H Auerbach sold $106K of PBYI at $5.88 — pre-scheduled 10b5-1 plan sale.